Skip to main content

Connor, Clark & Lunn Investment Management Ltd.

Position in MIRM — Mirum Pharmaceuticals, Inc.

CIK 1596800 VANCOUVER, A1

Position in MIRM

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$44,293,992
+$3,088,701 QoQ
Shares Held
479,476
-8.1% QoQ
Ownership
0.786%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
15 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in MIRM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $706,217,774 across 100 Biotechnology names. MIRM ranks #4 (6.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 MIRM
Mirum Pharmaceuticals, Inc.
This page
479,476 $44,293,992

All Filings in MIRM

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $44,293,992 479,476
2025-12-31 $41,205,291 521,652
2025-09-30 $36,360,000 495,976
2025-06-30 $21,564,332 423,744
2025-03-31 $16,050,233 356,276
2024-12-31 $7,317,296 176,960
2024-09-30 $2,627,625 67,375
2024-06-30 $1,567,577 45,849
2023-12-31 $3,941,717 133,527
2023-09-30 $3,605,844 114,109
2023-06-30 $976,333 37,740
2022-09-30 $224,575 10,689
2022-06-30 $281,644 14,473
2022-03-31 $506,614 23,007
2021-12-31 $408,607 25,618